Editor's choice:Using in vitro and in vivo models, this study identifies an important role for CCL2–CCR2 signaling in skeletal muscle wasting associated with breast cancer, with important implications for therapeutic targeting. This evidence concerns the gene CCR2 and breast carcinoma.